Autophagy-related IFNG is a prognostic and immunochemotherapeutic biomarker of COAD patients

Background Numerous studies have shown autophagy affects cellular immune responses. This study aims to explore prognosis and immunotherapeutic biomarkers related to autophagy in colon adenocarcinoma (COAD). Methods Based on R software, we performed the ssGSEA, differential expression analysis, Kaplan-Meier survival analysis, correlation analysis, and enrichment analysis. For wet experiment, we did qRT-PCR, immunohistochemistry and CCK-8 experiments. Results Using autophagy-related genes (ARGs) and the ssGSEA, COAD patients were divided into low and high autophagy groups. For immune score, stromal score, tumor purity, tumor infiltrating immune cells, co-signaling molecules, tumor mutational burden, microsatellite instability, mismatch repair, immune-related pathways, immune signatures, somatic mutations and subtype analysis, high autophagy group might benefit more from immunotherapy. Among 232 ARGs, IFNG was generally significantly correlated with tumor immunotherapy biomarkers (PD-L1, CD8A and cytotoxic T lymphocytes (CTL)). The disease-free survival of high IFNG group was significantly longer than that of low group. On above-mentioned immune-related research, the high IFNG group reached the same conclusion. The qRT-PCR and IHC analysis confirmed that IFNG was significantly higher expressed in dMMR samples compared to pMMR samples. For chemotherapy, the autophagy and IFNG were significantly negatively related to the chemosensitivity to cisplatin; IFNG inhibitor glucosamine increased cisplatin chemoresistance while IFNG increased cisplatin chemosensitivity; IFNG could reverse glucosamine induced chemoresistance. The functional enrichment analysis of IFNG, PD-L1, CD8A and 20 similar proteins were related to the activation of the immune system. The GSEA and ceRNA network partly described interaction mechanisms of IFNG with PD-L1 and CD8A. Conclusion Autophagy score and IFNG expression were novel immunotherapy predictive biomarkers, which might play predictive effects through the JAK-STAT signaling pathway. IFNG might be a potential targeted therapy for cisplatin resistant colon cancer. Besides, IFNG was also a prognostic indicator.

[1]  Wanqing Chen,et al.  Cancer statistics in China and United States, 2022: profiles, trends, and determinants , 2022, Chinese medical journal.

[2]  R. Qi,et al.  Constructe a novel 5 hypoxia genes signature for cervical cancer , 2021, Cancer cell international.

[3]  L. Tong,et al.  LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p , 2021, Apoptosis.

[4]  Takaaki Masuda,et al.  Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer , 2021, Cancer medicine.

[5]  Yue Xu,et al.  m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer , 2021, Frontiers in Cell and Developmental Biology.

[6]  Feng Zhu,et al.  FGD5-AS1 promotes cisplatin resistance of human lung adenocarcinoma cell via the miR-142-5p/PD-L1 axis , 2020, International journal of molecular medicine.

[7]  Henghui Zhang,et al.  The mutational pattern of homologous recombination-related (HRR) genes in Chinese colon cancer and its relevance to immunotherapy responses , 2020, Aging.

[8]  Zhenxiang Li,et al.  CMTM6 is positively correlated with PD-L1 expression and immune cells infiltration in lung squamous carcinoma. , 2020, International immunopharmacology.

[9]  Z. Dai,et al.  Overexpressed Pseudogene HLA-DPB2 Promotes Tumor Immune Infiltrates by Regulating HLA-DPB1 and Indicates a Better Prognosis in Breast Cancer , 2020, Frontiers in Oncology.

[10]  Wei Sun,et al.  Integrative analysis of competitive endogenous RNA network reveals the regulatory role of non-coding RNAs in high-glucose-induced human retinal endothelial cells , 2020, PeerJ.

[11]  Yan-yan Li,et al.  Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma , 2020, BioMed research international.

[12]  Brian Craft,et al.  Visualizing and interpreting cancer genomics data via the Xena platform , 2020, Nature Biotechnology.

[13]  Xiaole Shirley Liu,et al.  TIMER2.0 for analysis of tumor-infiltrating immune cells , 2020, Nucleic Acids Res..

[14]  X. Liu,et al.  Large-scale public data reuse to model immunotherapy response and resistance , 2020, Genome Medicine.

[15]  Xiaoping Chen,et al.  Gene expression and methylation profiles identified CXCL3 and CXCL8 as key genes for diagnosis and prognosis of colon adenocarcinoma , 2019, Journal of cellular physiology.

[16]  Matthew D. Smith,et al.  Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. , 2019, The Journal of clinical investigation.

[17]  R. Luo,et al.  Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment , 2019, Clinical Cancer Research.

[18]  Guan Sun,et al.  Mechanisms and therapeutic potentials of cancer immunotherapy in combination with radiotherapy and/or chemotherapy. , 2019, Cancer letters.

[19]  D. Gozuacik,et al.  Autophagy as a molecular target for cancer treatment. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[20]  Qin Li,et al.  Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy , 2019, Journal of Hematology & Oncology.

[21]  Miho Suzuki,et al.  Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade , 2019, AntiCancer Research.

[22]  Jan Gorodkin,et al.  Cytoscape stringApp: Network analysis and visualization of proteomics data , 2018, bioRxiv.

[23]  Yassen Assenov,et al.  Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.

[24]  R. Boidot,et al.  Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy , 2018, British Journal of Cancer.

[25]  Betty Y. S. Kim,et al.  Increased vessel perfusion predicts the efficacy of immune checkpoint blockade , 2018, The Journal of clinical investigation.

[26]  Chandra Sekhar Pedamallu,et al.  Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas. , 2018, Cancer cell.

[27]  Steven J. M. Jones,et al.  The Immune Landscape of Cancer , 2018, Immunity.

[28]  John L Marshall,et al.  Landscape of Tumor Mutation Load, Mismatch Repair Deficiency, and PD-L1 Expression in a Large Patient Cohort of Gastrointestinal Cancers , 2018, Molecular Cancer Research.

[29]  J. Zhai,et al.  Competing endogenous RNA network analysis of CD274, IL‑10 and FOXP3 co‑expression in laryngeal squamous cell carcinoma. , 2017, Molecular medicine reports.

[30]  H. Kwok,et al.  Abstract 108:In vitroandin vivocharacterization of novel scorpion venom-based peptides for the treatment of colon cancer , 2017 .

[31]  Levi Garraway,et al.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.

[32]  M. Muc-Wierzgoń,et al.  Tumor-Associated Macrophages and Regulatory T Cells Infiltration and the Clinical Outcome in Colorectal Cancer , 2017, Archivum Immunologiae et Therapiae Experimentalis.

[33]  Jian Su,et al.  Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinoma , 2016, Clinical Cancer Research.

[34]  P. Laurent-Puig,et al.  Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression , 2016, Genome Biology.

[35]  S. Aiba,et al.  Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma. , 2016, Journal of dermatological science.

[36]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[37]  T. Saitoh,et al.  Autophagy and autophagy-related proteins in the immune system , 2015, Nature Immunology.

[38]  Jianfei Huang,et al.  Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer , 2015, Scientific Reports.

[39]  N. Hacohen,et al.  Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity , 2015, Cell.

[40]  Paul Geeleher,et al.  pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels , 2014, PloS one.

[41]  Hui Zhou,et al.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..

[42]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[43]  Shizuo Akira,et al.  Autophagy in infection, inflammation and immunity , 2013, Nature Reviews Immunology.

[44]  Mira Ayadi,et al.  Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value , 2013, PLoS medicine.

[45]  Peter Cresswell,et al.  Pathways of antigen processing. , 2013, Annual review of immunology.

[46]  Martha L Slattery,et al.  JAK/STAT/SOCS‐signaling pathway and colon and rectal cancer , 2013, Molecular carcinogenesis.

[47]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[48]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[49]  Chi-Ying F. Huang,et al.  miRTarBase: a database curates experimentally validated microRNA–target interactions , 2010, Nucleic Acids Res..

[50]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[51]  Guo-Min Li,et al.  Mechanisms and functions of DNA mismatch repair , 2008, Cell Research.

[52]  You-Wen He,et al.  A critical role for the autophagy gene Atg5 in T cell survival and proliferation , 2007, The Journal of experimental medicine.

[53]  D. Lu,et al.  Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro. , 2006, Investigative ophthalmology & visual science.

[54]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[56]  Kitamura,et al.  Sodium butyrate blocks interferon‐gamma (IFN‐γ)‐induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells , 1999, Clinical and experimental immunology.

[57]  D. Goeddel,et al.  Structure of the human immune interferon gene , 1982, Nature.